Plants Archives | San Diego Biotechnology ConnectionSan Diego Biotechnology Connection

Drought tolerant corn, Monsanto, San Diego Biotechnology Connection

Drought-tolerant corn reveals plant biotech promise in parched Midwest

September 18, 2012 no comments

By Rex Graham Growing up in Iowa, the sarcastic saying we overused was something was about as exciting as watching the corn grow. But this year’s massive drought in the U.S. Corn Belt revealed Read More

Circadian clocks key to health, crop productivity

September 2, 2011 no comments

By Rex Graham UC San Diego researchers are determining what makes circadian clocks tick. These 24-hour rhythms are ubiquitous in nature and understanding how they work could pave the way to improved Read More

Stock Daily Change

ADMP	0.70	+0.02
AEMD	0.10	0.00
AHRO	0.79	+0.09
AIMM	0.005	+0.0015
AMGN	105.91	+0.29
ANX	0.733	0.00
APRI	2.58	-0.07
ARNA	8.301	+0.241
ATEC	1.95	+0.01
AVNR	3.41	+0.01
AVTO	0.005	0.00
AXMP	0.015	0.00
AXRX	0.16	0.00
CADX	6.91	-0.06
CELG	122.58	-1.06
CORX	0.045	-0.005
CXM	0.09	-0.0049
CYTX	2.50	-0.07
CYTR	2.361	+0.021
DRAD	2.40	0.00
DXCM	20.30	+0.03
ENTB	0.0025	+0.0004
FOLD	3.40	-0.02
HALO	7.42	-0.03
HRBR	0.19	0.00
IAGXQ	0.179	0.00
ILMN	70.31	-0.77
IMBI	0.028	0.00
ISCO	0.27	-0.02
ISIS	20.98	+0.34
IVRO	0.0235	+0.005
LGND	27.47	-0.48
LIFE	74.04	+0.10
LJPC	0.085	+0.008
LPTN	4.99	+0.05
MCK	117.31	+0.03
MEDS	1.10	0.00
MEIP	8.22	-0.10
MLPH	0.018	0.00
MNKD	6.55	-0.30
MNOV	3.14	-0.03
MRIC	1.20	0.00
NAII	4.60	0.00
NBIX	13.17	+0.46
NRDCQ	0.0001	0.00
NUXP	0.0016	0.00
ONCS	0.316	+0.007
OPTR	14.48	-0.19
OREX	6.45	-0.03
PCRX	29.30	-0.43
PFE	29.04	-0.07
QDEL	22.62	+0.52
RHHBY	65.96	+0.40
RMD	49.43	-0.59
SNTS	22.56	-0.37
SQNM	4.03	-0.05
TSRX	7.95	+0.05
VOLC	17.265	+0.265
VRX	84.47	+9.80
VRNM	2.2099	-0.0201
VVUS	14.82	+0.32
ZGNX	1.53	-0.04

2013-05-24 15:59

@SDBiotech

Trius Therapeutics: New, Positive Dimension For Investment Outlook http://t.co/rcVXC57kkN $CBST $TEVA $TSRX
11 days ago
Retweet
@ilus_art Gorgeous way to celebrate art, biology and cells.
20 days ago
Retweet
Trius Therapeutics releases persuasive safety study of potent new antibiotic against MRSA #superbug. http://t.co/uRBiPHj14U
26 days ago
Retweet
Halozyme initiates Phase 2 trial of drug to treat stage 4 pancreatic cancer. http://t.co/U9cjxGbtIL
32 days ago
Retweet
Illumina’s stronger than expected revenue up 21% sends shares up 13%. http://t.co/qviU0MYLQ3
32 days ago
Retweet
Trius presenting clinical-trial results Apr. 27 http://t.co/MCFeBYi57w on tedizolid, a potent MRSA antibiotic. http://t.co/myB421ZD2n
32 days ago
Retweet
After Thermo Fisher Scientific buys Life Technologies, sequencing leader Illumina may finally sell. http://t.co/F92ndBP0z2
40 days ago
Retweet
http://t.co/y8xbsAQ4q8
64 days ago
Retweet
FDA reviewing diabetes drugs causing pancreas precancers. Affected: Lilly, Merck, Novo Nordisk, Bristol-Myers. http://t.co/2dPyRAYLsc
71 days ago
Retweet

San Diego Biotechnology Connection

The share price of Trius Therapeutics (TSRX) has rebounded almost fully from its 10 percent dip in the New Year that was triggered by its public offering of 7 million shares; however, uncertainty about the company’s lead investigational drug is a lingering February hangover. Small investors face a dilemma: should they dump their diluted shares, double down? Our story explains why we recommend doubling down: http://sandiegobiotechnology.com/topics/5733/trius-dump-or-double-down-on-maker-of-mrsa-antibiotic/
103 days ago
A Glaxo Smith Kline genital herpes vaccine recently flopped in a large clinical trial, but “next generation” genital herpes vaccines by Genocea Biosciences, Agenus, Inc., and San Diego-based Vical, Inc., offer new hope. http://sandiegobiotechnology.com/topics/5600/glaxo-genital-herpes-vaccine-flops-but-genocea-a-buy-in-vaccine-space/
162 days ago
The Dow was off 1.82 percent, down 243.36 points to 13,102.53 at the close of trading Oct. 23 amid disappointing earnings reports. But 11 publicly traded San Diego biotechs gained for the day. https://sandiegobiotechnology.com/topics/5443/eleven-san-diego-biotech-stocks-rise-amid-tuesday-plunge-in-dow/
213 days ago
Millions of infertile women will soon get the biggest baby boost in a generation from preimplantation genetic diagnosis (PGD), which identifies their healthiest embryos at in vitro fertilization (IVF) clinics. These blastocysts, embryos with 50-150 cells, are at a very favorable stage for implantation and pregnancy. The inner cell mass will give rise to the actual cells of the fetus. The other cells that surround and protect the inner cell mass give rise to the fetal part of the placenta. Photo: Robert Shabanowitz, Gesinger Medical Center
215 days ago
It’s more than a 5-hour energy jolt. Cardium Therapeutics’ purchase of To Go Brands and its nationwide marketing network will give the San Diego biotech company a permanent sales boost for its own nutritional supplements -- and a larger piece of the $30 billion supplements market. https://sandiegobiotechnology.com/topics/5393/cardium-boosts-energy-supplement-sales-with-national-marketing-muscle/
235 days ago